The Limited Times

Now you can see non-English news...

Bambin Gesù, Car-t therapy for inoperable tumors of children

2022-04-12T16:40:59.614Z


It inhibited its growth in tests for severe brain diseases (ANSA) Researchers at the Bambino Gesù Pediatric Hospital have developed a potential treatment for diffuse midline gliomas, aggressive, inoperable and currently untreated brain tumors. The treatment consists of a mix of gene and drug therapy which, in laboratory tests, inhibited tumor growth. "The new treatment strategy has provided promising pre-clinical results and could represent the first step in su


Researchers at the Bambino Gesù Pediatric Hospital have developed a potential treatment for diffuse midline gliomas, aggressive, inoperable and currently untreated brain tumors.

The treatment consists of a mix of gene and drug therapy which, in laboratory tests, inhibited tumor growth.

"The new treatment strategy has provided promising pre-clinical results and could represent the first step in successfully treating a proportion of patients suffering from this terrible form of cancer," said Franco Locatelli.

The study was conducted on tumor cells from glioma patients.

Through a drug screening, the researchers identified an experimental drug never tested in this pathology (Linsitinib) that has been shown to exert a direct antitumor action on cancer cells.

This molecule was accompanied by the use of Car-T cells programmed to recognize and kill cancer cells by attacking a protein expressed on their surface: the GD2 antigen. 

The use of the combined strategy in laboratory experiments has been shown to inhibit tumor growth.

The researchers also showed that the combination produces a more effective anticancer effect than the two treatments used separately. 

Despite the positive results, human trials will not be immediate, the researchers warn.

It will first be necessary to develop better ways to deliver the drug and Car-T directly to the tumor site and carry out further tests to better understand what the immune and inflammatory response in patients may be. 

The study was conducted in collaboration with the Higher Institute of Health, the Gemelli Polyclinic and the Institute of Cancer Research in London.

The findings were published in the journal Neuro-Oncology.


Source: ansa

All life articles on 2022-04-12

You may like

Life/Entertain 2024-02-20T10:00:49.765Z
Life/Entertain 2024-02-19T11:02:16.119Z

Trends 24h

Life/Entertain 2024-03-28T17:17:20.523Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.